Charles Schwab’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.16M | Buy |
2,130,899
+226,758
| +12% | +$442K | ﹤0.01% | 2408 |
|
|
2025
Q1 | $3.35M | Sell |
1,904,141
-41,842
| -2% | -$73.6K | ﹤0.01% | 2438 |
|
|
2024
Q4 | $5.18M | Buy |
1,945,983
+551,968
| +40% | +$1.47M | ﹤0.01% | 2323 |
|
|
2024
Q3 | $3.19M | Buy |
1,394,015
+60,590
| +5% | +$139K | ﹤0.01% | 2569 |
|
|
2024
Q2 | $3.89M | Buy |
1,333,425
+185,398
| +16% | +$541K | ﹤0.01% | 2455 |
|
|
2024
Q1 | $4.18M | Buy |
1,148,027
+21,364
| +2% | +$77.8K | ﹤0.01% | 2344 |
|
|
2023
Q4 | $1.7M | Buy |
1,126,663
+84,510
| +8% | +$128K | ﹤0.01% | 2665 |
|
|
2023
Q3 | $1.4M | Buy |
1,042,153
+2,363
| +0.2% | +$3.17K | ﹤0.01% | 2693 |
|
|
2023
Q2 | $1.87M | Buy |
1,039,790
+85,989
| +9% | +$155K | ﹤0.01% | 2568 |
|
|
2023
Q1 | $1.58M | Buy |
953,801
+65,675
| +7% | +$109K | ﹤0.01% | 2584 |
|
|
2022
Q4 | $1.71M | Sell |
888,126
-74,617
| -8% | -$143K | ﹤0.01% | 2617 |
|
|
2022
Q3 | $2.16M | Buy |
962,743
+138,558
| +17% | +$310K | ﹤0.01% | 2563 |
|
|
2022
Q2 | $2.67M | Sell |
824,185
-116,852
| -12% | -$379K | ﹤0.01% | 2469 |
|
|
2022
Q1 | $4.95M | Buy |
941,037
+33,364
| +4% | +$176K | ﹤0.01% | 2281 |
|
|
2021
Q4 | $7.72M | Buy |
907,673
+212,255
| +31% | +$1.8M | ﹤0.01% | 2135 |
|
|
2021
Q3 | $6.91M | Buy |
695,418
+317,882
| +84% | +$3.16M | ﹤0.01% | 2220 |
|
|
2021
Q2 | $3.52M | Buy |
377,536
+82,092
| +28% | +$764K | ﹤0.01% | 2521 |
|
|
2021
Q1 | $3.09M | Buy |
+295,444
| New | +$3.09M | ﹤0.01% | 2528 |
|